Phosphaturic Tumor-Induced Osteomalacia

被引:0
|
作者
Ashouri, Diana [1 ]
Kastoon, Tony [2 ]
机构
[1] Univ Calif Riverside, Internal Med, Riverside, CA USA
[2] Univ Calif Riverside, Endocrinol & Obes Med, Riverside, CA 92521 USA
关键词
fgf-23; hyperphosphaturia; hypophosphatemia; osteomalacia; tumor -induced osteomalacia;
D O I
10.7759/cureus.54712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumor-induced osteomalacia (TIO) is a rare complication of certain tumors involving the skeletal bones, mainly in the lower extremities and rarely the spine, that can cause skeletal abnormalities, osteopenia, and osteoporosis. The etiology of these tumors is unknown, and they are considered benign tumors that usually localize in bone or soft tissue anywhere in the body. Symptoms are nonspecific and vague, which causes a delay in diagnosis. These tumors produce fibroblast growth factor-23, which causes hypophosphatemia due to renal wasting of phosphate and inhibits vitamin D3 activation, resulting in osteomalacia. The majority of these tumors are osteoblastic and rarely osteolytic. A PET scan can detect the location and diagnose these tumors. Surgical resection, when feasible, is the treatment of choice and can lead to improvement, resolution of symptoms, and correction of hypophosphatemia. Patients usually present with a wide variety of nonspecific complaints. This case report presents an unusual presentation of TIO from a phosphaturic mesenchymal tumor involving the left acetabulum.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Tumor-Induced Osteomalacia
    Pablo Florenzano
    Iris R. Hartley
    Macarena Jimenez
    Kelly Roszko
    Rachel I. Gafni
    Michael T. Collins
    Calcified Tissue International, 2021, 108 : 128 - 142
  • [22] Successful cryoablation for a phosphaturic mesenchymal tumor in the maxilla causing tumor-induced osteomalacia: a case report
    Yindong Liu
    Mengyao Guo
    Xiaoding Liu
    Huanwen Wu
    Yan Jiang
    Zhiwei Wang
    Hongli Jing
    Weibo Xia
    Jizhi Zhao
    Lian Zhou
    Archives of Osteoporosis, 20 (1)
  • [23] Tumor-induced osteomalacia
    Chong, William H.
    Molinolo, Alfredo A.
    Chen, Clara C.
    Collins, Michael T.
    ENDOCRINE-RELATED CANCER, 2011, 18 (03) : R53 - R77
  • [24] TUMOR-INDUCED OSTEOMALACIA
    IOAKIMIDIS, DE
    DENDRINOS, GK
    FRANGIA, KB
    BABIOLAKIS, DN
    CHILAS, GI
    LYBEROPOULOS, KL
    KONTOMERKOS, TK
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (06) : 1162 - 1164
  • [25] TUMOR-INDUCED OSTEOMALACIA
    Mastaglia, Silvina
    Somoza, Julia
    Gonzalez, Diana
    Oliveri, Beatriz
    ACTUALIZACIONES EN OSTEOLOGIA, 2013, 9 (02) : 194 - 202
  • [26] Tumor-induced osteomalacia
    Vollbrecht, Jill E.
    Rao, D. Sudhaker
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12): : 1282 - 1282
  • [27] TUMOR-INDUCED OSTEOMALACIA
    SCHAPIRA, D
    BENIZHAK, O
    NACHTIGAL, A
    BURSTEIN, A
    BARSHALOM, R
    SHAGRAWI, I
    BEST, LA
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1995, 25 (01) : 35 - 46
  • [28] Tumor-induced osteomalacia
    de Beur, SMJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (10): : 1260 - 1267
  • [29] Tumor-induced osteomalacia
    Pouchot, J
    Grasland, A
    Paycha, F
    Vinceneux, P
    REVUE DE MEDECINE INTERNE, 2003, 24 : 250S - 252S
  • [30] Tumor-induced osteomalacia
    Annamalai, Anand K.
    Shinto, Ajit
    Aram, Subramanian
    Prabhu, Veeranathevar Ananji
    Santhi, Radhakrishnan
    Gopalakrishnan, Chandrasekaran
    Chelian, Mathirajan
    Srinivasan, Kaliappan Gurusamy
    KIDNEY INTERNATIONAL, 2022, 102 (05) : 1194 - 1194